Clinical Trials & Research

Researchers from the United Kingdom have appraised the most recent assessment by the European Food Safety Authority regarding the safety of aspartame, a popular type of artificial sweetener. The investigators caution that the commission’s findings may be misleading. Is aspartame really as safe as official reports claim? Some researchers are unsure. Aspartame is perhaps the
0 Comments
Laboratory and animal studies have suggested that the leukemia drug nilotinib could alleviate symptoms of Parkinson’s disease. Now, using early results from a clinical trial in humans, scientists have worked out how the drug reduces toxic protein and raises dopamine levels in the brain. New research explains how a cancer drug increases levels of the
0 Comments
A series of clinical trials have tested an experimental treatment for Parkinson’s disease that uses a novel approach: administering the drug straight into the brain via implanted ports. The leading researchers believe this may be a “breakthrough” therapeutic strategy for neurological conditions. Newly trialed therapy could launch a fresh chapter in the treatment of Parkinson’s
0 Comments
A preliminary clinical trial shows that stem cell transplantation, along with a tolerable dose of chemotherapy, is safe and more effective at slowing down multiple sclerosis than other existing therapies. Scientists were able to slow down MS progression in a new clinical trial using stem cell transplantation. Multiple sclerosis (MS) is a chronic neurodegenerative condition
0 Comments
New research has revealed that targeted cognitive training can successfully reduce cognitive impairment in treatment-resistant schizophrenia. Altering certain neural pathways may improve cognitive ability in people with treatment-resistant schizophrenia. Schizophrenia is one of the 15 leading causes of disability globally. In the United States, this condition affects more than 3 million people. Symptoms of schizophrenia
0 Comments
For the first time in decades, researchers have identifed a new medication that can successfully treat major depression. An existing oral drug may relieve major depression. Depression affects about 300 million people across the globe, making the condition the “leading cause of ill health and disability worldwide,” according to the World Health Organization (WHO). In
0 Comments
Researchers created a database for the daily circadian rhythms of genetic activity. The findings may help physicians time the delivery of drugs in accordance with a person’s body clock, boosting treatment for cardiovascular disease and other conditions. Our body clock can influence how effective drugs are — especially for treating cardiovascular problems. Our circadian rhythm,
0 Comments